Through breakthrough innovation, Supbio is redefining the boundaries of precision diagnostics. Powered by globally leading ultra-sensitive quantitative detection technologies, we push beyond the limits of conventional sensitivity and enable a shift from simple detection to precise measurement. Supbio has built an integrated platform spanning research and development, quality management, and global regulatory certification. This foundation accelerates the clinical translation and real-world application of precision diagnostics across major diseases. Discover how innovation is shaping the future of healthcare.

Supbio provides comprehensive solutions spanning products, technical services, medical testing, research collaboration, and intellectual property partnerships. In addition to precision diagnostic reagents and supporting products, we offer instrument validation, operational training, result interpretation, and quality control support. Our services also include third-party medical testing and integrated O2O testing solutions designed to support both clinical and research needs. We actively collaborate with research institutions and industry partners to accelerate clinical translation and innovation. Supbio also enables patent licensing and customized manufacturing partnerships, helping transform innovative technologies into real-world applications. Explore how our integrated solutions can support your needs.

Supbio specializes in molecular diagnostics, offering a portfolio of highly sensitive and specific detection kits. Our products support precise nucleic acid detection for pathogens including HIV, HBV, and Mycobacterium tuberculosis, as well as exosome isolation and nucleic acid extraction and purification. These technologies support both infectious disease diagnostics and life science research. Built on reliable platforms such as real-time PCR (qPCR) fluorescent probe technology, our products deliver accurate and efficient testing solutions for clinical and research laboratories, helping advance the practice of precision medicine.

Built on proprietary, internationally advanced technologies, Supbio focuses on critical clinical needs and emerging healthcare challenges to deliver precise and efficient solutions for our partners. In recent years, we have introduced innovative clinical solutions including comprehensive HIV-1 genotypic drug resistance testing and technologies for extracellular vesicle and viral isolation and enrichment. These innovations provide new capabilities for low viral load detection, drug resistance analysis, and advanced biomedical research.